A KEY Type 2 diabetes drug has been pulled off shelves in Bahrain’s pharmacies over reports that it might contain unacceptable levels of carcinogenic impurities.
The National Health Regulatory Authority (NHRA) said yesterday the withdrawal follows a Saudi Food and Drug Administration (SFDA) announcement that Metformin tablets contained high levels of a cancer-causing ingredient Nitrosodimethylamine (NDMA) .